Table of Contents
PALMETTO, Fla. — ScriptAbility is now integrated with McKesson Corp’s EnterpriseRx. This arrangement allows EnterpriseRx pharmacy clients to help ensure medication adherence and safety by providing accessible prescription labels for their patients who are visually impaired or have limited English proficiency.
ScriptAbility is an accessible labeling solution founded by En-Vision America. It allows pharmacists to provide their patients with ScripTalk Talking Labels, ScriptView Large Print Labels, Dual Language/Translated Labels, Braille Labels and Controlled Substance Safety Labels (CSSLs).
Through this integration, pharmacists who use EnterpriseRx can pre-populate the patient information into the ScriptAbility labelling software using a barcode scan and then print the accessible label that suits their patient’s needs.
“We applaud McKesson for facilitating this important linkage with ScriptAbility,” says David Raistrick of En-Vision America. “Each patient is unique, and their labeling needs vary. With this integration, McKesson helps to ensure that the software can provide more effective and safer access to medication information.”
“We continue to look for new ways to advance the entire landscape of pharmacy technology, which includes fostering a healthcare environment that prioritizes inclusivity and patient safety” says Maureen Meyer, Vice President of Product Management at McKesson.
